Mechanisms of Anticholinesterase Interference with Tau Aggregation Inhibitor Activity in a Tau-Transgenic Mouse Model

BACKGROUND: Symptomatic treatments of Alzheimer’s Disease (AD) with cholinesterase inhibitors and/or memantine are relatively ineffective and there is a need for new treatments targeting the underlying pathology of AD. In most of the failed disease-modifying trials, patients have been allowed to con...

Descripción completa

Detalles Bibliográficos
Autores principales: Riedel, Gernot, Klein, Jochen, Niewiadomska, Grazyna, Kondak, Constantin, Schwab, Karima, Lauer, Dilyara, Magbagbeolu, Mandy, Steczkowska, Marta, Zadrozny, Maciej, Wydrych, Malgorzata, Cranston, Anna, Melis, Valeria, Santos, Renato X., Theuring, Franz, Harrington, Charles R., Wischik, Claude M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403648/
https://www.ncbi.nlm.nih.gov/pubmed/32091331
http://dx.doi.org/10.2174/1567205017666200224120926

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403648/
https://www.ncbi.nlm.nih.gov/pubmed/32091331
http://dx.doi.org/10.2174/1567205017666200224120926

Ejemplares similares